Latest News
October 14, 2020
Not intended for U.S. and UK Media
Combination of copanlisib and rituximab significantly prolonged progression-free survival of patients with relapsed indolent non-Hodgkin's Lymphoma
September 30, 2020
Bayer to accelerate transformation to address challenging market environment and enable additional growth investments
September 15, 2020
Not intended for U.S. and UK Media
Bayer and Systems Oncology sign exclusive license agreement on innovative breast cancer treatment approach ERSO™